Contact
Please use this form to send email to PR contact of this press release:
INVESTOR NOTICE: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important April 20 Deadline – IMVT, HSACU, HSAC, HSACW
TO: